Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(20%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
3
30%
Ph phase_2
7
70%

Phase Distribution

0

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
7(70.0%)
Phase 3Large-scale testing
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(4)

Detailed Status

Completed4
Not yet recruiting4
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 27 (70.0%)
Phase 33 (30.0%)

Trials by Status

completed440%
not_yet_recruiting440%
recruiting110%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10